Global Health Data Exchange - Discover the World's Health Data

Recently Added Records

Global Rheumatic Heart Disease Endemicity Index (RHDEI) Estimates and Forecasts 1990-2041 File icon

This dataset includes estimates and forecasts created using a new methodology for conceptualizing locations at risk for high RHD morbidity and mortality, or burden, globally. Researchers utilized a set of covariates produced by the Global Burden of Disease Study from 1990-2021 via principal component analysis to create the rheumatic heart disease endemicity index (RHDEI). They then We then demonstrated how the RHDEI could be used in forecasting for targeted policy change with the use of an ensemble time series forecasting model, creating 20 years of estimates through 2041. The results were evaluated via out-of-sample forecasting to estimate model performance and compared to a naive model to assess goodness-of-fit.

Global Burden of Disease Study (GBD) Disability Weights to US National Electronic Injury Surveillance System - All Injury Program (NEISS-AIP) Injury Types Mapping File icon

Disability weights were estimated for 492 injury types identified in the US National Electronic Injury Surveillance System - All Injury Program (NEISS-AIP) using disability weights from the Global Burden of Disease Study (GBD). These estimates were developed through a collaboration between the Centers for Disease Control and Prevention (CDC) and the Institute for Health Metrics and Evaluation (IHME). The resulting dataset provides estimated disability weights, along with corresponding uncertainty, for all injury types in NEISS-AIP. Each injury type is categorized by injured body part and injury diagnosis. These estimates are based on GBD disability weights and injury incidence data in the United States from 2015 to 2020.

Global Burden of Disease (GBD 2021) Association of Southeast Asian Nations Smoking Prevalence and Burden Estimates 1990-2021 File icon

The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories and selected subnational locations. This data set includes estimates for the ASEAN region, comprised of Brunei Darussalam, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, Singapore, Thailand, and Viet Nam.

This dataset contains tobacco smoking exposure prevalence and burden of disease estimates for 1990-2021. Smoking exposure was defined as the age-standardized prevalence of any current use of smoked tobacco among adults age 15 and older, as well as adolescents aged 10-14. Smoked tobacco included cigarettes, cigars, pipes, hookahs, and local products, such as bidis and kreteks. Estimates include both the proportion of the population and number of individuals exposed, amount of tobacco consumed, and deaths and years of life lost to disability by cause.

Tanzania - Kigoma Health Facility Assessment of Emergency Obstetric and Neonatal Care Services 2023 File icon

The CDC's Division of Reproductive Health conducted a sustainability evaluation to assess changes following the end of the Reducing Maternal Mortality in Tanzania Project in the remote Kigoma region of western Tanzania. This follow-up survey collected data on changes in emergency obstetric and neonatal care (EmONC) capacity and quality, maternal and neonatal care and family planning, pregnancy outcomes, and maternal morbidity and mortality. Data were collected by visiting 202 health facilities and administering an enhanced health facility assessment (HFA) questionnaire.

Results of the survey are reported in "2023 Health Facility Assessment of Emergency Obstetric and Neonatal Care Services in Kigoma Region, Tanzania".

2023 Pregnancy Outcomes in Health Facilities in Kigoma Region, Tanzania File icon

The CDC's Division of Reproductive Health led a sustainability evaluation to examine changes in maternal and newborn health services since the end of the Reducing Maternal Mortality in Tanzania Project in the remote Kigoma region of western Tanzania in 2019. This evaluation collected and analyzed data on maternal and perinatal health outcomes as well as the capacity and functionality of emergency obstetric and neonatal care (EmONC) services.

This sustainability evaluation used a pregnancy outcomes monitoring system (POMS) method to collect and examine data from 202 health facilities. This method collects data from labor and delivery registers, operating theater registers, admission and discharge registers, case notes, in-patient postpartum care registers, nurses' report books, and obstetric wards daily reports. The evaluation also employed a modified form of Rapid Ascertainment Process for Institutional Deaths (RAPID), a method that aims to identify all maternal deaths occurring in a facility.

Global Sexual Violence Against Children Prevalence Estimates 1990-2023 File icon

Sexual violence against children (SVAC) is a pervasive health and human rights issue that curtails the safety and wellbeing of children globally and accounts for a substantial portion of morbidity. To counter SVAC’s compounding impacts on health and development, there have been increasing investments in global movements towards prevention and ending SVAC and other forms of violence against children. However, the future success of such prevention efforts relies on accurately monitoring and characterizing experiences of SVAC. This dataset provides estimates on the prevalence of contact SVAC before the age of 18 for 204 countries by age and sex, from 1990 to 2023. It also contains information on the age at which survivors of lifetime sexual violence first experienced sexual violence.

Global Brain Health Spending 2000-2019 File icon

As part of the Brain Health Initiative (BHI) at IHME, this project produced estimates for global spending on health care services for 24 brain health disorders in 204 countries and territories by condition, location, year, age, sex, and type of care for 2000-2019. Types of care include ambulatory, emergency department, home health, inpatient, nursing facility, and pharmaceutical. This study utilizes estimates of relative prices and utilization of health care service from the Disease Expenditure Project (DEX), prevalence and incidence measures from the 2023 Global Burden of Disease Study (GBD), and spending scalars developed from the Financing Global Health study (FGH).

These estimates can be explored using the Brain health atlas website. https://brainhealthatlas.org/

Get data files

United States Healthy Life Expectancy by County, Race, and Ethnicity 2009-2019 File icon

Estimates were produced for HALE (healthy life expectancy) at the merged county level in the United States, by racial and ethnic population, for each year from 2009 to 2019. These estimates were produced using population data from the National Center for Health Statistics; covariate data derived from the American Community Survey, Behavioral Risk Factor Surveillance System, Gallup Daily survey, and estimates of Years Lived with Disability (YLDs) from the Global Burden of Diseases 2021 study.

This data set includes the following:

  • CSV files of marge county-, state-, and national-level estimates of HALE for each age group, sex, year, and racial and ethnic population: Latino, American Indian or Alaska Native (AIAN), Asian or Pacific Islander (Asian), Black, White. Blank cells are for masked estimates.
  • Code used to generate the estimates.

Global Burden of Disease Study 2021 (GBD 2021) Unsafe Water Exposure Estimates 1990-2021 File icon

The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories and selected subnational locations.

This dataset contains unsafe water exposure estimates by for 1990-2021. Exposure to unsafe water is defined based on the primary water source used and the use of water treatment to improve water quality. Primary water sources include basic piped (fecal contaminated piped water), improved (including boreholes, tube wells, protected wells, and packaged or delivered water), and unimproved (including unprotected springs, unprotected wells, and surface water). Water treatment methods include boil/filter, solar/chlorine, and no treatment. Estimates include both the proportion of the population and number of individuals exposed.

Get data files

Global Burden of Disease Study 2021 (GBD 2021) Unsafe Sanitation Exposure Estimates 1990-2021 File icon

The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories and selected subnational locations.

This dataset contains unsafe sanitation exposure estimates by year, location, age, sex, and primary toilet type for the years 1990-2021. Exposure to unsafe sanitation is defined based on the primary toilet type used. Toilet types include unimproved facilities (pit latrines without a slab, hanging or bucket latrines, and open defecation), and improved facilities (pit latrines with slabs, and composting toilets). Estimates include both the proportion of the population exposed and the number of individuals within the given population that are exposed. Estimates include mean, and the 95% uncertainty intervals. Only mean estimates are available for both sex.

Global Burden of Disease Study 2021 (GBD 2021) Hygiene Exposure Estimates 1990-2021 File icon

The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories and selected subnational locations.

This dataset contains no access to handwashing facility exposure estimates by year, location, age, and sex for the years 1990-2021. Exposure to no access to handwashing facility is defined as lack of access to a handwashing facility which includes soap (bar, liquid, or powder/detergent), water, and wash station (either permanent or mobile). This is a binary variable, i.e. one is either exposed or not exposed to a handwashing facility. Estimates include both the proportion of the population exposed and the number of individuals within the given population that are exposed. Estimates include mean, and the 95% uncertainty intervals. Only mean estimates are available for both sexes.

Global Burden of Disease Study 2021 (GBD 2021) Child and Adolescent Overweight and Obesity Estimates and Forecasts 1990-2050 File icon

The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories.

This dataset provides annual estimates for the prevalence of overweight and obesity across various child and adolescent age groups from 1990 to 2021, with projections from 2022 to 2050. The estimates are based on data sources from the GBD 2021 analyses.

Global Burden of Disease Study 2021 (GBD 2021) Adult Overweight and Obesity Prevalence Estimates and Forecasts 1990-2050 File icon

The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories.

This dataset provides annual estimates for the prevalence of overweight and obesity across various adult age groups from 1990 to 2021, with projections from 2022 to 2050. The estimates are based on data sources from the GBD 2021 analyses.

Global Burden of Disease Study 2023 (GBD 2023) Routine Childhood Vaccination Coverage Estimates and Forecasts 1980-2030 File icon

Estimates of vaccination coverage for 11 childhood vaccines (first-dose bacillus Calmette-Guérin [BCG], first- and third-dose diphtheria-tetanus-pertussis [DTP1, DTP3], third-dose hepatitis B [HepB3], third-dose Haemophilus influenzae type b [Hib3], first- and second-dose measles [MCV1, MCV2], third-dose pneumococcal conjugate vaccine [PCV3], third-dose polio [Pol3], first-dose rubella-containing vaccine [RCV1], and complete rotavirus [RotaC, two or three doses]) were produced for 204 countries and territories between 1980 and 2023 as part of the Global Burden of Disease Study 2023 (GBD 2023). The estimation process primarily used household survey microdata, household survey report data in the absence of microdata, and estimates of country-reported coverage data. Forecasted coverage was estimated from 2024 to 2030 for DTP3, MCV2 and PCV3 under reference, better, and worse scenarios.

Health Effects of Violence Against Children Burden of Proof and Risk-Outcome Scores File icon

Researchers systematically reviewed literature on the health burden of physical violence, psychological violence, and neglect during childhood. Utilizing the Burden of Proof (BoP) methodology, a meta-analytical approach that generates conservative measures of association while accounting for heterogeneity between input studies, the authors summarized the relationship between these forms of violence against children and 35 adverse health outcomes. This dataset comprises: a list detailing all studies incorporated into our analysis; processed input data from each included study; and results for each exposure-outcome BoP analysis, including pooled relative risks and BoP-specific metrics (i.e., burden of proof risk function, risk-outcome score, and star rating).

Global Burden of Disease Study 2021 (GBD 2021) Europe Life Expectancy Change by Cause 1990-2021 File icon

The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 16 European Economic Area (EEA) countries (Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden) and the United Kingdom (England, Northern Ireland, Scotland, Wales). This dataset includes estimates for life expectancy decomposition for 1990-2021. Data sources used to produce the estimates came from GBD 2021. Other estimates used to support this analysis (life expectancy (LE), summary exposure values (SEV), and population) can be accessed in the GBD 2021 Results Tool.

Global Burden of Disease Study 2021 (GBD 2021) Suicide Mortality and Incidence 1990-2021 File icon

The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories and selected subnational locations.

This dataset includes estimates of the mean age of death, the fraction of suicide attempts (incident cases) to the number of deaths due to suicides, the ratio of incident cases to deaths, the number and percentage of suicide deaths that occurred from firearms, for males and females, globally and for each GBD region in 2021. The results also include a comparison of age-standardised mortality rate per 100,000 due to suicide by sex and region in 1990, 2019, and 2021. A variety of data were gathered to inform these estimates, including vital registration data, verbal autopsy data, and mortality surveillance data that included 23,782 study-location-years of data from GBD 2021.

United States Health Care Spending Variation 2019 File icon

The Disease Expenditure Project (DEX) at IHME analyzed estimates for US spending on health care across 3,110 US counties to examine cost variation in 2019. Data for 4 key drivers of per capita spending were extracted for 3110 US counties, 148 health conditions, 38 age-sex groups, 4 payers, and 7 types of care. Service utilization was measured as service volume per prevalent case, while price and intensity was measured as spending per visit, admission, or prescription. This dataset contains the results of Das Gupta and Shapley decomposition methods and linear regression used to estimate the contribution of each factor.

United States Homicide Rates by County, Race, Ethnicity, Age, and Sex 2000-2019 File icon

Homicide and homicide due to firearm rate estimates were produced at the county level in the United States, and by racial and ethnic population, for each year between 2000-2019. These estimates were generated using population and deaths data from the National Center for Health Statistics.

This dataset includes the following:

  • CSV files of county-, state-, and national-level estimates of homicide and firearm-related homicide rates for each age group, sex, year, and racial and ethnic population (non-Latino and non-Hispanic American Indian or Alaska Native [AIAN], non-Latino and non-Hispanic Asian or Pacific Islander [Asian], non-Latino and non-Hispanic Black [Black], Latino or Hispanic [Latino], and non-Latino and non-Hispanic White [White]). Blank cells are for masked estimates.
  • Code used to generate the estimates.

United States Diabetes Mortality by County, Race, and Ethnicity 2000-2019 File icon

Diabetes mortality rate estimates were produced at the county level in the United States, and by racial and ethnic population, for each year between 2000-2019. These estimates were generated using population and deaths data from the National Center for Health Statistics.

This dataset includes the following:

  • CSV files of county-, state-, and national-level estimates of diabetes mortality rates for each age group, sex, year, and racial and ethnic population (non-Latino and non-Hispanic American Indian or Alaska Native [AIAN], non-Latino and non-Hispanic Asian or Pacific Islander [Asian], non-Latino and non-Hispanic Black [Black], Latino or Hispanic [Latino], and non-Latino and non-Hispanic White [White]). Blank cells are for masked estimates.
  • Code used to generate the estimates.

Global Health Effects of Gender-Based Violence Burden of Proof and Risk-Outcome Scores File icon

Researchers systematically reviewed literature on the health burden of physical, sexual, and psychological gender-based violence impacting both men and women. Employing the Burden of Proof (BoP) methodology, a meta-analytical approach designed to produce conservative estimates of associations while heterogeneity between input studies analyzed, the researchers delineated the relationship between these forms of violence against men and women and eighth adverse health outcomes. Data were extracted and synthesized from 40 unique studies. This dataset includes: a comprehensive list of all the studies incorporated into our analysis; the processed input data from each study included; and the outcomes for each exposure-outcome analysis according to the Burden of Proof (BoP) methodology, including pooled relative risks and BoP-specific metrics (i.e., burden of proof risk function, risk-outcome score, and star rating).

Zimbabwe Demographic and Health Survey 2023-2024

The Zimbabwe Demographic and Health Survey (DHS) 2023-2024 is part of phase 8 of the Demographic and Health Survey series. Topics commonly covered in DHS include: child and maternal health, family planning, nutrition, health behavior and knowledge, health care access and use, domestic violence, and immunization. For the 2023-2024 Zimbabwe DHS, 9,666 women ages 15-49 and 4,185 men ages 15-54 were successfully interviewed from 10,725 households. Additionally, anemia testing anthropometry measurements were performed for men, women, and children ages 0-59 months.

United States Life Expectancy by County and Educational Attainment 2000-2019 File icon

Estimates were produced for mortality rates and life expectancy at the merged county level in the United States, and by educational attainment population, for each year 2000 to 2019. These estimates were produced using population and deaths data from the National Center for Health Statistics.

This data set includes the following:

  • CSV files of merged county-, state-, and national-level estimates of mortality rates and life expectancy for each age group, sex, year, and racial-ethnic group (all of which are non-Latino, except for the Latino group): White, Black, American Indian Alaska Native (AIAN), Asian Pacific Island (API), and Latino. Blank cells are for masked estimates.
  • Code used to generate the estimates.

Global Malaria Spending by Program Area 2000-2020 File icon

Research by the IHME estimated malaria spending for 106 countries which were malaria-endemic over 2000-2020 or became malaria-free after 2000. These estimates cover malaria spending disaggregated by source into three domestic financing sources (government, out-of-pocket, and prepaid private) and development assistance for health (DAH). Government spending and DAH estimates are disaggregated by ten malaria program areas. Domestic spending estimates were produced from a diverse set of data, including National Malaria Control Programs, the WHO’s World Malaria Reports (WMRs), the WHO’s Global Health Expenditure Database (GHED), country spending estimates reported to the Pan American Health Organization (PAHO), country spending estimates reported to the Global Fund to Fight AIDS, Tuberculosis, and Malaria, and National Health Accounts (NHAs). Development Assistance for Malaria data were drawn from IHME’s 2021 Development Assistance for Health Database. Estimates are reported in constant 2021 USD.

Global Burden of Disease Study 2021 (GBD 2021) United States Burden of Disease Forecasts 2022-2050 File icon

The Global Burden of Disease Study 2021 (GBD 2021) for USA states, coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for the United States of America and each individual State.

This dataset provides annual estimates for summary exposure values (SEVs), deaths, years of life lost (YLLs), years lived with disability (YLDs), disability adjusted life years (DALYs), life expectancy, and healthy life expectancy for 2022-2050. Data sources used to produce the estimates came from GBD 2019 and GBD 2021 analyses.

Global Burden of Disease Study 2021 (GBD 2021) HIV Lifetime Probability of Acquisition and Prevalence of Unsuppressed Viraemia Estimates and Forecasts 1990-2050 File icon

This dataset contains estimates of the period lifetime probability of HIV acquisition, which quantifies the hypothetical probability of acquiring HIV for a “synthetic cohort”, a simulated population that is aged from birth to death through the set of age-specific incidence rates of a given time period. Using GBD 2021 HIV estimates, the prevalence of unsuppressed viraemia (PUV), which represents the proportion of the population without a suppressed level of HIV (viral load <1000 copies/mL) was also estimated. Forecasts for mortality, prevalence, and incidence through 2050 were also created.

Global Burden of Disease Study 2021 (GBD 2021) Global Nutrition Targets Estimates and Forecasts 1990-2050 File icon

The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories. Six global nutrition targets (GNTs) related to low birthweight, exclusive breastfeeding, child growth (i.e., wasting, stunting, and overweight), and anemia among females of reproductive age were chosen by the World Health Assembly in 2012.

This dataset provides annual estimates for the prevalence and expected prevalence based on socio-demographic index (SDI) of the six GNT indicators in relevant age groups from 1990 to 2021, with projections of prevalence from 2022 to 2050. It also provides annual estimates for the attributable burden of the indicators in the years 2012 and 2021, and the annual estimates for livebirths and population in relevant age groups from 1990 to 2021, with population projections from 2022 to 2050. The estimates are based on data sources used in GBD 2021.

United States Human Development Index Estimates 2008-2021 File icon

Human Development Index (HDI) is a composite metric encompassing information about longevity, education, and income. HDI estimates were produced at an individual level and summarized at the population level by race and ethnicity, sex, age, and location. These estimates were generated using data from the American Community Survey and the National Vital Statistics System. Please refer to the Data Release Information Sheet for this dataset for more information on the estimates and input data included.

United States Overweight and Obesity Prevalence Estimates and Forecasts 1990-2050 File icon

The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories.

This dataset provides annual estimates for the prevalence of overweight and obesity across various age groups from 1990 to 2021, with projections from 2022 to 2050. The estimates are based on data sources from the GBD 2021 analyses.

Global Burden of Disease Study 2021 (GBD 2021) Smoking Mortality and Prevalence Forecasts 2022-2050 File icon

The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories.

This dataset provides annual estimates for deaths and years of life lost (YLLs) for 2022-2050 in three smoking prevalence scenarios. Data sources used to produce the estimates came from GBD 2019 and GBD 2021 analyses.

Get YLL count data files
Get YLL rate data files

Global Burden of Disease Study 2021 (GBD 2021) Lead Exposure Estimates 1990-2021 File icon

The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories and selected subnational locations.

This dataset contains estimates for blood and bone lead exposure and intelligence quotient (IQ) shift by year, location, age, and sex for the years 1990-2021. Blood lead exposure is measured as micrograms of lead per deciliter of blood. Bone lead exposure is measured as micrograms of lead per gram of bone. Intelligence quotient shift is the number of IQ points an individual has below a score of 100 due to blood lead exposure. Estimates re also provided for the proportion of the population above a given threshold of blood lead exposure. Thresholds include 5 and 10 μg/dL. Estimates include the mean and 95% uncertainty intervals. 

Global Burden of Disease Study 2021 (GBD 2021) Nervous System Disorders Estimates 1990-2021 File icon

The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories and selected subnational locations.

This dataset provides estimates for disability-adjusted life years (DALYs), years lived with disability (YLDs), years of life lost (YLLs), prevalence, and deaths for 37 individual conditions that impact the nervous system and aggregate health loss across all 37 conditions. Supplemental materials linked to the online publication describe data availability per condition.

Global Burden of Disease Study 2021 (GBD 2021) Bacterial Antimicrobial Resistance Burden Estimates 1990-2021 and Forecasts 2022-2050 File icon

The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories and selected subnational locations.

This dataset provides annual estimates for age-specific fertility rate (ASFR), total fertility fate (TFR) and live births for 1950-2100. Data sources used to produce the estimates came from 8709 country-years of vital and sample registrations, 1455 surveys and censuses, and 150 other sources.

United States Life Expectancy Disparities Among Ten Americas by Sex and Age Group 2000-2021 File icon

Life expectancy estimates were produced in the United States between 2000-2021, for 10 mutually exclusive and collectively exhaustive Americas defined based on race and ethnicity, geographical location, metropolitan status, income and Black-White residential segregation, by sex, age group and year. These estimates were generated using population and deaths data from the National Center for Health Statistics.

This dataset includes the following:

  • Estimates of life expectancy for each sex, age group, year and America
  • Assignments of the Ten Americas classification for each combination of county and race and ethnicity
  • Code used to generate the estimates

Development Assistance for Health Database 1990-2023 File icon

This version of the Development Assistance for Health (DAH) Database includes estimates for 1990-2023, which are based on project databases, financial statements, annual reports, IRS 990s, and correspondence with agencies. The DAH Database enables comprehensive analysis of trends in international disbursements of grants and loans for health projects in low- and middle-income countries from key agencies. The data are disaggregated by source of funds, channel of funding, country and geographic region, health focus areas, and program areas.

To better understand the data and how to use it, please refer to the IHME DAH Database 2023 User Guide.

Development Assistance for Health on COVID-19 Database 2020-2023 File icon

Development Assistance for Health (DAH) on COVID-19 produced estimates for 2020-2023, which are based on project databases, financial statements, annual reports, IRS 990s, and correspondence with agencies. The DAH Database enables comprehensive analysis of trends in international disbursements of grants and loans for COVID-19-related health projects in low- and middle-income countries from key agencies. The data are disaggregated by source of funds, channel of funding, country and geographic region, and program areas.

Lesotho Demographic and Health Survey 2023-2024

The Lesotho Demographic and Health Survey 2023-2024 is part of phase 8 of the Demographic and Health Survey (DHS) series, a nationally representative household survey series. Topics commonly covered in DHS include: child and maternal health, family planning, nutrition, health behaviors, health care access, health care use, and immunization. For the 2014 Lesotho DHS, 6,413 women age 15-49 and 3,215 men age 15-59 were successfully interviewed from 9,810 households. Blood tests were conducted for the presence of anemia and HIV infection in men and women, and for anemia in children age 6-59 months from a subsample of households.

United States Cirrhosis Mortality by County, Race, and Ethnicity 2000-2019 File icon

Cirrhosis mortality rate estimates were produced at the county level in the United States, by racial and ethnic population, for each year between 2000-2019. These estimates were generated using population and deaths data from the National Center for Health Statistics.

This dataset includes the following:

  • CSV files of county-, state-, and national-level estimates of cirrhosis mortality rates for each age group, sex, year, and racial and ethnic population (non-Latino and non-Hispanic American Indian or Alaska Native [AIAN], non-Latino and non-Hispanic Asian or Pacific Islander [Asian], non-Latino and non-Hispanic Black [Black], Latino or Hispanic [Latino], and non-Latino and non-Hispanic White [White]). Blank cells are for masked estimates.
  • Code used to generate the estimates.

United States Mortality Due to Falls by County, Age, Race, and Ethnicity 2000-2019 File icon

Fall-related mortality rate estimates at the county level in the United States, and by racial/ethnic group, for each year between 2000-2019. These estimates were produced using population and deaths data from the National Center for Health Statistics.

This dataset includes the following:

  • CSV files of county-, state-, and national-level estimates of fall-related mortality rates for each age group, sex, year, and racial-ethnic group (non-Hispanic White [White], non Hispanic Black [Black], non-Hispanic Asian or Pacific Islander [Asian], non-Hispanic American Indian Alaska Native [AIAN], and Hispanic or Latino [Latino]). Blank cells are for masked estimates
  • Code used to generate the estimates

Global Burden of Disease Study 2021 (GBD 2021) Air Pollution Exposure Estimates and Risk Curves 1990-2021 File icon

The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories and selected subnational locations.

This dataset provides air pollution exposure estimates for nitrogen dioxide pollution, ozone pollution, ambient particulate matter pollution, and household air pollution. Population-weighted exposure summary files are provided for all air pollution risk factors, and gridded exposure files are provided for nitrogen dioxide, ozone, and ambient particulate matter pollution. Also provided are estimates for relative risks due to exposure to particulate matter for ischemic heart disease, stroke, chronic obstructive pulmonary disease, lung cancer, acute lower respiratory infection, type 2 diabetes mellitus, as well as gestational age shifts.

Global Burden of Disease Study 2021 (GBD 2021) Dietary Risk Exposure Estimates 1990-2021 File icon

The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories and selected subnational locations.

Estimates of 15 dietary risks and the burden attributable to these were produced for 1990-2021. Files available in this record include estimates of the daily intake of the 15 GBD food groups (either in grams or percent energy) by location, year, age, and sex. Estimates of disease burden attributable to dietary risks are available through the GBD Results Tool.

Measles Seroprevalence Systematic Review and Bias Assessment 1962-2019 File icon

Researchers at IHME and the London School of Hygiene and Tropical Medicine (LSHTM) conducted a systematic review and bias assessment of all primary data on measles seroprevalence in low- and middle-income countries published from 1962-2021. 

Global Burden of Disease Study 2021 (GBD 2021) Covariates 1980-2021 File icon

The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories and selected subnational locations.

Covariates, which are independent variables with a positive or negative relationship to GBD diseases and conditions, are used to inform the estimation process in models in all components and stages of the GBD study. Types of covariates used include socioeconomic, demographic, health system access, climate, and food consumption. This dataset contains data for covariates for 1980-2021 used in the GBD 2021 study.

For additional GBD results and resources, visit the GBD 2021 Data Resources page.

Global Burden of 85 Pathogens 1990-2019 File icon

The Global Burden of Disease Study 2019 coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories and selected subnational locations. The Global Burden of Antimicrobial Resistance (GRAM) estimates the burden of pathogens, infectious syndromes and antimicrobial resistance.

This dataset includes disability-adjusted life-years (DALYs) associated with 85 pathogens in 2019, globally, regionally, and for 204 countries and territories.

Global Burden of Disease Study 2021 (GBD 2021) Mortality and Life Expectancy Forecasts 2022-2050 File icon

The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories.

This dataset provides annual estimates for summary exposure values (SEVs), deaths, years of life lost (YLLs), years lived with disability (YLDs), disability adjusted life years (DALYs), life expectancy, healthy life expectancy and life expectancy decomposition for 2022-2050. Data sources used to produce the estimates came from GBD 2019 and GBD 2021 analyses.

Gross Domestic Product Per Capita 1960-2050 - FGH 2023 File icon

Research by the Global Burden of Disease Health Financing Collaborator Network produced estimates for Gross Domestic Product (GDP) from 1960-2050. Estimates are reported as GDP per person in constant 2022 purchasing-power parity-adjusted (PPP) dollars. 

Global Health Spending 1995-2021 File icon

Research by the Global Burden of Disease Health Financing Collaborator Network produced retrospective health spending estimates for 1995-2021 for 204 countries and territories. The estimates cover total health spending, health spending disaggregated by source into three domestic financing source categories (government, out-of-pocket, and prepaid private), and development assistance for health (DAH). Domestic health spending source data came primarily from the WHO’s Global Health Expenditure Database (GHED). DAH data came from a diverse set of sources, including program reports, budget data, national estimates, and National Health Accounts (NHAs). The resulting estimates were used to forecast GDP and prospective health spending estimates for 2022-2050. Estimates are reported in constant 2022 United States Dollars, constant 2022 purchasing power parity adjusted (PPP) dollars, and as a percent of gross domestic product.

Global Expected Health Spending 2022-2050 File icon

Research by the Global Burden of Disease Health Financing Collaborator Network produced projected health spending estimates for 2022-2050 for 204 countries and territories. The estimates cover total health spending, health spending disaggregated by source into three domestic financing source categories (government, out-of-pocket, and prepaid private), and development assistance for health (DAH). Retrospective health spending estimates for 1995-2022 and key covariates (including GDP per capita, total government spending, total fertility rate, and fraction of the population older than 65 years) were used to forecast GDP and health spending through 2050. Estimates are reported in constant 2022 US dollars, constant 2022 purchasing-power parity-adjusted (PPP) dollars, and as a percent of gross domestic product.

GHDx: Recent Subscribe